{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:26:46Z","timestamp":1760264806133},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1038\/ncprheum0037","type":"journal-article","created":{"date-parts":[[2005,11,10]],"date-time":"2005-11-10T16:04:01Z","timestamp":1131638641000},"page":"55-59","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Coronary artery disease in patients with systemic lupus erythematosus"],"prefix":"10.1038","volume":"1","author":[{"given":"Michael","family":"Galindo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorinda","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth D","family":"Crockett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliza F","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncprheum0037_CR1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.rdc.2005.01.001","volume":"31","author":"M Nikpour","year":"2005","unstructured":"Nikpour M et al. (2005) Premature atherosclerosis in systemic lupus erythematosus. Rheum Dis Clin North Am 31: 329\u2013354","journal-title":"Rheum Dis Clin North Am"},{"key":"BFncprheum0037_CR2","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1002\/art.20622","volume":"50","author":"SMA Toloza","year":"2004","unstructured":"Toloza SMA et al. (2004) Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XXIII. Baseline predictors of vascular events. Arthritis Rheum 50: 3947\u20133957","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0037_CR3","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/art.21039","volume":"52","author":"BJ Fessler","year":"2005","unstructured":"Fessler BJ et al. (2005) Systemic lupus erythematosus in three ethnic groups XVI. Association of hydroxychloroquine use with reduced risk of damage accrual. Arthritis Rheum 52: 1473\u20131480","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0037_CR4","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","volume":"145","author":"S Manzi","year":"1997","unstructured":"Manzi S et al. (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 145: 408\u2013415","journal-title":"Am J Epidemiol"},{"key":"BFncprheum0037_CR5","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1136\/ard.62.11.1066","volume":"62","author":"EM Sella","year":"2003","unstructured":"Sella EM et al. (2003) Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus. Ann Rheum Dis 62: 1066\u20131070","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0037_CR6","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0002-9149(98)00963-1","volume":"83","author":"Y Kwok","year":"1999","unstructured":"Kwok Y et al. (1999) Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 83: 660\u2013666","journal-title":"Am J Cardiol"},{"key":"BFncprheum0037_CR7","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1093\/rheumatology\/keh581","volume":"44","author":"S Jimenez","year":"2005","unstructured":"Jimenez S et al. (2005) Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology 44: 756\u2013761","journal-title":"Rheumatology"},{"key":"BFncprheum0037_CR8","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa035611","volume":"349","author":"Y Asanuma","year":"2003","unstructured":"Asanuma Y et al. (2003) Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 349: 2407\u20132415","journal-title":"N Engl J Med"},{"key":"BFncprheum0037_CR9","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.athoracsur.2004.10.052","volume":"79","author":"TJ Birdas","year":"2005","unstructured":"Birdas TJ et al. (2005) Outcomes of coronary artery bypass grafting in patients with connective tissue diseases. Ann Thorac Surg 79: 1610\u20131614","journal-title":"Ann Thorac Surg"},{"key":"BFncprheum0037_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/rheumatology\/keg436","volume":"43","author":"J Wajed","year":"2004","unstructured":"Wajed J et al. (2004) Prevention of cardiovascular disease in systemic lupus erythematosus\u2014proposed guidelines for risk factor management. Rheumatology 43: 7\u201312","journal-title":"Rheumatology"},{"key":"BFncprheum0037_CR11","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1001\/archinte.160.13.2042","volume":"160","author":"DG Wahl","year":"2000","unstructured":"Wahl DG et al. (2000) Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis. Arch Int Med 160: 2042\u20132048","journal-title":"Arch Int Med"},{"key":"BFncprheum0037_CR12","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1056\/NEJMoa050613","volume":"352","author":"PM Ridker","year":"2005","unstructured":"Ridker PM et al. (2005) A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 352: 1293\u20131304","journal-title":"N Engl J Med"},{"key":"BFncprheum0037_CR13","doi-asserted-by":"crossref","unstructured":"Antithrombotic Trialists' Collaboration (2002) Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324: 71\u201386","DOI":"10.1136\/bmj.324.7329.71"},{"key":"BFncprheum0037_CR14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.atherosclerosis.2004.08.005","volume":"177","author":"S Kang","year":"2004","unstructured":"Kang S et al. (2004) Effects of statin therapy on the progression of carotid atherosclerosis: a systematic review and meta-analysis. Atherosclerosis 177: 433\u2013442","journal-title":"Atherosclerosis"},{"key":"BFncprheum0037_CR15","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1191\/0961203303lu2135oa","volume":"14","author":"EC Jury","year":"2005","unstructured":"Jury EC and Ehrenstein MR (2005) Statins: immunomodulators for autoimmune rheumatic disease? Lupus 14: 192\u2013196","journal-title":"Lupus"},{"issue":"Suppl","key":"BFncprheum0037_CR16","first-page":"S406","volume":"50","author":"A Kiana","year":"2004","unstructured":"Kiana A and Petri M (2004) Predictors of statin toxicity in the Lupus Atherosclerosis Prevention Study [abstract]. Arthritis Rheum 50 (Suppl): S406","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0037_CR17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/0002-9343(94)90151-1","volume":"96","author":"M Petri","year":"1994","unstructured":"Petri M et al. (1994) Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. Am J Med 96: 254\u2013259","journal-title":"Am J Med"}],"container-title":["Nature Clinical Practice Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncprheum0037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncprheum0037","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncprheum0037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/ncprheum0037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T19:05:18Z","timestamp":1659121518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncprheum0037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["BFncprheum0037"],"URL":"https:\/\/doi.org\/10.1038\/ncprheum0037","relation":{},"ISSN":["1745-8382","1745-8390"],"issn-type":[{"value":"1745-8382","type":"print"},{"value":"1745-8390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"22 June 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}